Media Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org.
An LLS representative will respond as soon as possible.
The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
Rye Brook, NY (Wednesday, Sept. 9, 2020) - With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first clinical trial dedicated solely to this most vulnerable population. This trial (LLS Protocol Number: BAML-16-001-COV1) will tes...
PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute Leukemia
September 3, 2020, Rye Brook, N.Y. and Raleigh, N.C. - The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announced today a partnership to launch a first-of-its-kind global master clinical trial to develop new treatments for children with relapsed acute leukemia. The new LLS PedAL (Pediatric Acute Leukemia) master clinical trial will test, simultaneously, multiple targeted therapies f...
National Students of the Year 2nd Runner-up
(Cranford, NJ, August 18, 2020) The effects of the COVID-19 pandemic are far reaching, and high school students are among those whose lives are being up-ended. Not only is this generation missing many traditional rites of passage, but they are graduating into a frightening world and an uncertain future. But, rather than feeling sorry for themselves, a very unique group of students across the country are fac...
Blood Cancer Patients Need Support Now More Than Ever
(Rye Brook, NY, Sept. 1, 2020) — Having blood cancer is tough. Having blood cancer now is even tougher. Blood Cancer Awareness Month in September provides an opportunity to remind the public about the urgent need to support research to fight this deadly disease — a disease that is diagnosed every three minutes in the U.S. and has no current means of prevention. As the global leader in the fight against blood canc...
LLS’s Team In Training Resilience Challenge Adds Meaning to Miles
An Innovative Virtual Challenge to Move, Fundraise, and Commemorate Blood Cancer Awareness Month Rye Brook, NY (August 25, 2020) – Having blood cancer is tough. Having blood cancer now is even tougher. The Leukemia & Lymphoma Society’s (LLS) Team In Training campaign is partnering with leading event technology platform, haku, to raise awareness and funds in support of LLS’s goal of cr...
Communities Nationwide Remain Laser-Focused on Helping Cancer Patients Who Can’t Wait For Pandemic to Go Away
(Rye Brook, NY, August 13, 2020) – Like many nonprofit organizations, The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer, is not immune to the damaging impact of the COVID-19 pandemic. But thousands of participants in nearly 100 communities across the country remain laser-focused on their pursuit of a world without blood cancer, taking on LLS’s 10-week philanthropic competition...
Celebrating Diversity Fueled High School Students to Break Fundraising Records for Cancer Cures
(RYE BROOK, NY, July 22, 2020) - The effects of the COVID-19 pandemic are far reaching, and high school students are among those whose lives are being up-ended. Not only is this generation missing many traditional rites of passage, but they are graduating into a frightening world and an uncertain future. But, rather than feeling sorry for themselves, a very unique group of students across the country are facing the c...
The Leukemia & Lymphoma Society Announces Board of Directors Officer Appointments and Welcomes Four New Members
RYE BROOK, NY, July 20, 2020 - The Leukemia & Lymphoma Society (LLS) announced today National Board Officer appointments and four new members to its National Board of Directors, who will work alongside LLS leadership to ensure that the organization continues to deliver its cancer curing mission and impact for patients, despite the challenges caused by the COVID-19 pandemic. Effective J...